Consensus Rating
Strong Buy
▲ Improved Q4 2025
Average Price Target
$92.40
▲ +8.4% upside
Active Analysts
25
3 new covers this quarter
Coverage Split
18 Buy 6 Hold 1 Sell
All Buy/Overweight Hold/Neutral Sell/Underweight Initiated Coverage
Firm / Analyst Rating Price Target Implied Upside Last Updated Action
Goldman Sachs
M. Reynolds, T. Vance
Buy $98.50 +14.9% Mar 12, 2026 View Report →
J.P. Morgan
S. Okoye
Overweight $94.00 +10.1% Mar 10, 2026 View Report →
Morgan Stanley
L. Chen, R. Patel
Overweight $91.20 +7.2% Feb 28, 2026 View Report →
Barclays
A. Foster
Equal Weight $82.00 -0.2% Feb 22, 2026 View Report →
UBS
K. Novak
Buy $89.50 +4.8% Feb 15, 2026 View Report →
Jefferies
P. Alvarez
Buy $96.00 +12.3% Jan 29, 2026 View Report →
Cowen
D. Mitchell
Market Perform $83.50 +1.5% Jan 20, 2026 View Report →
Credit Suisse
E. Dubois
Underperform $72.00 -11.3% Jan 08, 2026 View Report →

Recent Research Notes

Q4 2025 Earnings Preview: Aerospace & Energy Lead Outperformance
Mar 14, 2026 · 24 min read
Goldman Sachs
Initiation of Coverage: Diversified Cash Flows Support Premium Valuation
Mar 05, 2026 · 18 min read
Piper Sandler
Energy Transition Play: Zenth's Fusion Roadmap Warrants Re-rating
Feb 27, 2026 · 21 min read
Jefferies
Healthcare Division Update: Gene Therapy Pipeline Advances Phase III
Feb 18, 2026 · 15 min read
UBS

Analyst & Media Inquiries

For research requests, data verification, or interviews with our divisional heads, please contact our dedicated Investor Relations team.

Schedule an Analyst Meeting
Elena Vasquez
VP, Investor Relations
elena.vasquez@aevumzenth.com
James Calloway
Director, Financial Communications
james.calloway@aevumzenth.com
Aevum Zenth IR Hotline
24/7 Analyst Support
+1 (212) 555-0198
}